Neuralstem, Inc. (CUR)
-NYSE MKT | Prev Close: | 2.69 |
|---|
| Open: | N/A |
|---|
| Bid: | 2.20 x 200 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 4.00 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 0.88 - 3.02 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 991,820 |
|---|
| Market Cap: | 192.73M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Neuralstem CEO To Present At Stem Cells & Regenerative Medicine CongressPR Newswire(Thu, Sep 26)
- Neuralstem: Evidence Increasingly Suggests Its Neural Stem Cells Are Effective In ALSat Seeking Alpha(Thu, Sep 19)
- Neuralstem, Inc. President and CEO Publishes New Blog Entitled “An ounce of action is worth a ton of theory”Accesswire(Mon, Sep 16)
- NEURALSTEM, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online(Tue, Sep 10)
- First Patient Treated In Phase II Of Neuralstem ALS Stem Cell TrialPR Newswire(Tue, Sep 10)
- Why Neuralstem Represents An Enormous Opportunity For Investorsat Seeking Alpha(Mon, Sep 9)
- NeoStem And Neuralstem: 2 Early Regenerative Medicine Winnersat Seeking Alpha(Sun, Sep 8)
- 5 Stocks Setting Up to Break Outat TheStreet(Fri, Sep 6)
- 4 Healthcare Stock Stories Making Sector Headlines Thursdayat Wall St. Cheat Sheet(Thu, Sep 5)
- Neuralstem To Raise $4 Million In Registered Direct OfferingPR Newswire(Thu, Sep 5)
- 4 Reasons NeoStem May See Significant Share Price Appreciationat Wall St. Cheat Sheet(Tue, Sep 3)
- Neuralstem, Inc. President and CEO Publishes New Blog Entitled “...Meetest for death, the weakest kind of fruit / Drops earliest to the ground, and so let me…”Accesswire(Tue, Sep 3)
- Neuralstem President And CEO To Present At The 2013 Rodman & Renshaw Annual Healthcare ConferencePR Newswire(Tue, Sep 3)
- 3 Biotech Stocks Under $10 to Watchat TheStreet(Fri, Aug 30)
- Biotech: A Scattershot Of Stem Cell Plays Following Yesterday's Bloodbathat Seeking Alpha(Tue, Aug 27)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 692.46 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.22 |
|---|
| Quarterly EPS Est
(Sep-13)
: | -0.04 |
|---|
| Mean Recommendation*: | 2.7 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds.
View More
0.41%